
Catherine R. Oliver-garcia
Examiner (ID: 9259, Phone: (571)272-2655 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2904, 2900, 2914 |
| Total Applications | 7479 |
| Issued Applications | 7429 |
| Pending Applications | 0 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5188487
[patent_doc_number] => 20070166795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Cytokine-like proteins'
[patent_app_type] => utility
[patent_app_number] => 11/716808
[patent_app_country] => US
[patent_app_date] => 2007-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10568
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166795.pdf
[firstpage_image] =>[orig_patent_app_number] => 11716808
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/716808 | Antibodies that bind to a member of the IL-6/G-CSF/MGF family | Mar 11, 2007 | Issued |
Array
(
[id] => 4949872
[patent_doc_number] => 20080305998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Ligand to GPR8 and DNA thereof'
[patent_app_type] => utility
[patent_app_number] => 11/699352
[patent_app_country] => US
[patent_app_date] => 2007-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 55812
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20080305998.pdf
[firstpage_image] =>[orig_patent_app_number] => 11699352
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/699352 | Ligand to GPR8 | Jan 25, 2007 | Issued |
Array
(
[id] => 5034205
[patent_doc_number] => 20070098744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Probiotic enterococci for improved immunity'
[patent_app_type] => utility
[patent_app_number] => 11/544120
[patent_app_country] => US
[patent_app_date] => 2006-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8233
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20070098744.pdf
[firstpage_image] =>[orig_patent_app_number] => 11544120
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/544120 | Probiotic enterococci for improved immunity | Oct 5, 2006 | Abandoned |
Array
(
[id] => 5199145
[patent_doc_number] => 20070298463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Variants of human glycoprotein hormone alpha chain: compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/429553
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 33267
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20070298463.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429553
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429553 | Variants of human glycoprotein hormone alpha chain: compositions and uses thereof | May 4, 2006 | Issued |
Array
(
[id] => 225052
[patent_doc_number] => 07605236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-20
[patent_title] => 'Antibodies that immunospecifically bind to B lymphocyte stimulator protein'
[patent_app_type] => utility
[patent_app_number] => 11/266444
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 179845
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/605/07605236.pdf
[firstpage_image] =>[orig_patent_app_number] => 11266444
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/266444 | Antibodies that immunospecifically bind to B lymphocyte stimulator protein | Nov 3, 2005 | Issued |
Array
(
[id] => 5887687
[patent_doc_number] => 20060275310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Method and detection and decontamination of antigens by nanoparticle-raman spectroscopy'
[patent_app_type] => utility
[patent_app_number] => 11/222093
[patent_app_country] => US
[patent_app_date] => 2005-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10021
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275310.pdf
[firstpage_image] =>[orig_patent_app_number] => 11222093
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/222093 | Method and detection and decontamination of antigens by nanoparticle-raman spectroscopy | Sep 7, 2005 | Abandoned |
Array
(
[id] => 7192904
[patent_doc_number] => 20050163757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Anti-microbial biotherapeutic agents: alternatives to conventional pharmaceutical antibiotics'
[patent_app_type] => utility
[patent_app_number] => 11/041498
[patent_app_country] => US
[patent_app_date] => 2005-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5927
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163757.pdf
[firstpage_image] =>[orig_patent_app_number] => 11041498
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/041498 | Anti-microbial biotherapeutic agents: alternatives to conventional pharmaceutical antibiotics | Jan 23, 2005 | Abandoned |
Array
(
[id] => 7423358
[patent_doc_number] => 20040265332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis'
[patent_app_type] => new
[patent_app_number] => 10/896778
[patent_app_country] => US
[patent_app_date] => 2004-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17259
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265332.pdf
[firstpage_image] =>[orig_patent_app_number] => 10896778
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/896778 | BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis | Jul 21, 2004 | Abandoned |
Array
(
[id] => 7427704
[patent_doc_number] => 20040209270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Method for identifying macrocyclic polyketides'
[patent_app_type] => new
[patent_app_number] => 10/486187
[patent_app_country] => US
[patent_app_date] => 2004-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4377
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209270.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486187
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486187 | Method for identifying macrocyclic polyketides | Feb 5, 2004 | Abandoned |
Array
(
[id] => 7020025
[patent_doc_number] => 20050222044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'AT4 RECEPTOR LIGANDS AS ANGIOGENIC, ANTI-ANGIOGENIC, AND ANTI-TUMOR AGENTS'
[patent_app_type] => utility
[patent_app_number] => 10/675470
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 4012
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10675470
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/675470 | AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents | Sep 29, 2003 | Issued |
Array
(
[id] => 7060536
[patent_doc_number] => 20050002896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture'
[patent_app_type] => utility
[patent_app_number] => 10/611914
[patent_app_country] => US
[patent_app_date] => 2003-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9655
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002896.pdf
[firstpage_image] =>[orig_patent_app_number] => 10611914
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/611914 | Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture | Jul 2, 2003 | Issued |
Array
(
[id] => 6664512
[patent_doc_number] => 20030203838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Compositions and methods for inhibiting angiogenesis'
[patent_app_type] => new
[patent_app_number] => 10/460296
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12763
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203838.pdf
[firstpage_image] =>[orig_patent_app_number] => 10460296
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/460296 | Compositions and methods for inhibiting angiogenesis | Jun 12, 2003 | Abandoned |
Array
(
[id] => 5710409
[patent_doc_number] => 20060051754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Transporter selectively transporting sulfate conjugate and its gene'
[patent_app_type] => utility
[patent_app_number] => 10/507755
[patent_app_country] => US
[patent_app_date] => 2003-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6663
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051754.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507755
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507755 | Transporter selectively transporting sulfate conjugate and its gene | Mar 12, 2003 | Abandoned |
Array
(
[id] => 6851418
[patent_doc_number] => 20030143621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Nuclear matrix proteins'
[patent_app_type] => new
[patent_app_number] => 10/354480
[patent_app_country] => US
[patent_app_date] => 2003-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14725
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143621.pdf
[firstpage_image] =>[orig_patent_app_number] => 10354480
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/354480 | Nuclear matrix proteins | Jan 28, 2003 | Abandoned |
Array
(
[id] => 6821265
[patent_doc_number] => 20030219426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Therapeutic antiangiogenic compositions and methods'
[patent_app_type] => new
[patent_app_number] => 10/351284
[patent_app_country] => US
[patent_app_date] => 2003-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16939
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219426.pdf
[firstpage_image] =>[orig_patent_app_number] => 10351284
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/351284 | Therapeutic antiangiogenic compositions and methods | Jan 23, 2003 | Abandoned |
Array
(
[id] => 7161131
[patent_doc_number] => 20050084862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Sample preparation for the detection of infectious agents'
[patent_app_type] => utility
[patent_app_number] => 10/500167
[patent_app_country] => US
[patent_app_date] => 2002-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3439
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500167
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500167 | Sample preparation for the detection of infectious agents | Dec 23, 2002 | Abandoned |
Array
(
[id] => 6856138
[patent_doc_number] => 20030129639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'GDU, a novel signalling protein'
[patent_app_type] => new
[patent_app_number] => 10/323001
[patent_app_country] => US
[patent_app_date] => 2002-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3174
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10323001
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/323001 | GDU, a novel signalling protein | Dec 17, 2002 | Abandoned |
Array
(
[id] => 8244767
[patent_doc_number] => 08202688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-19
[patent_title] => 'Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant'
[patent_app_type] => utility
[patent_app_number] => 10/300247
[patent_app_country] => US
[patent_app_date] => 2002-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 23010
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/202/08202688.pdf
[firstpage_image] =>[orig_patent_app_number] => 10300247
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/300247 | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant | Nov 19, 2002 | Issued |
Array
(
[id] => 663675
[patent_doc_number] => 07101985
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-05
[patent_title] => 'Methods and compositions in checkpoint signaling'
[patent_app_type] => utility
[patent_app_number] => 10/300453
[patent_app_country] => US
[patent_app_date] => 2002-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 26
[patent_no_of_words] => 34357
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/101/07101985.pdf
[firstpage_image] =>[orig_patent_app_number] => 10300453
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/300453 | Methods and compositions in checkpoint signaling | Nov 19, 2002 | Issued |
| 60/509037 | Methods for treating cancer by inhibiting Wnt signaling | Oct 3, 2002 | Pending |